InPlex™ CF is Third Wave's FDA approved molecular test for cystic fibrosis. The test simultaneously detects and identifies CF mutations in patient DNA samples. InPlex™ CF delivers the accuracy of Third Wave's Invader® chemistry in an easy-to-use micro fluidic card developed in collaboration with 3M Co.
Click here to learn more about why InPlexTM CF format is becoming the method of choice
The Invader® chemistry is protected by foreign and domestic patents.